Skip to content
Screener

LivaNova LIVN Total Cost of Revenue

Total Cost of Revenue at other companies

Abbott logo
AbbottABT
$5.33B+9.7%
Haemonetics logo
HaemoneticsHAE
$136.58M+5.8%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$4.02M-22.4%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$27.67M-9.9%
Medtronic logo
MedtronicMDT
$3.4B+8.0%
ITG
Integer HoldingsITGR
$329.99M+4.1%

Segments

By segment

See full
Cardiopulmonary$97.27M+1.9%
Neuromodulation$14.46M-2.1%

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net revenue$390,587$352,524$752,845$669,379
Cost of sales116,917113,536235,426214,137
Gross profit273,670238,988517,419455,242
Operating expenses:
Selling, general, and administrative158,128137,780301,696266,926
Research and development53,66247,185112,35785,064
Other operating expense12,396(160)12,411452
Operating income49,48454,18390,955102,800

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's total cost of revenue?
LivaNova (LIVN) reported total cost of revenue of $116.92M in Q2 2026.
How has LivaNova's total cost of revenue changed year-over-year?
LivaNova's total cost of revenue increased by 3.0% year-over-year, from $113.54M to $116.92M.
What is the long-term trend for LivaNova's total cost of revenue?
Over 4 years (2021 to 2025), LivaNova's total cost of revenue has grown at a 8.0% compound annual growth rate (CAGR), from $329.37M to $448.18M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about LivaNova's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude